eHealth is an overarching term used today to describe the application of information and communications technologies in the health sector. It encompasses a whole range of purposes from purely administrative through to health care delivery. For example: within the hospital care setting, eHealth refers to electronic patient administration systems; laboratory and radiology information systems; electronic messaging systems; and, telemedicine — …
Health Canada releases new data on cannabis use
The 2023 Canadian Cannabis Survey provides important insights into Canadians’ knowledge, attitudes and behaviours on cannabis use Ottawa – Health Canada published the results of the 2023 Canadian Cannabis Survey (CCS). The data was collected from May 2 to July 20, 2023. This is the seventh cycle of the Canadian Cannabis Survey, which Health Canada has conducted every year since 2017. The …
Zebra blinds with chain, chain guard by Multi-Stores recalled
Ottawa -Health Canada has determined that the recalled blinds do not meet the Corded Window Coverings Regulations and pose a strangulation hazard. Young children may pull looped cords around their neck, or become entangled in the cords, causing a strangulation hazard and even death. In addition, the products can also release small parts that present a choking hazard to young children. Children …
HEALTH CANADA APPROVES PFIZER CANADA’S GENE THERAPY IN HEMOPHILIA B
KIRKLAND – Pfizer Canada ULC announced that Health Canada approved BEQVEZ (fidanacogene elaparvovec), an adeno-associated viral (AAV) vector-based gene therapy for the treatment of adults (aged 18 years or older) with moderately severe to severe hemophilia B (congenital Factor IX (FIX) deficiency) who are negative for neutralizing antibodies to variant AAV serotype Rh74. “Pfizer has more than 30 years of …
MODERNA ASKS HEALTH CANADA TO REVIEW ITS RSV VACCINE, mRNA-1345
mRNA-1345 is an investigational vaccine for the prevention of RSV in adults aged 60 years or older TORONTO – Moderna Biopharma Canada Corp. has announced the filing of a New Drug Submission (NDS) to Health Canada for mRNA-1345, its investigational vaccine candidate for the prevention of RSV in adults aged 60 years or older. This is the first mRNA vaccine …
Canadians don’t have access to many antibiotics
Ottawa – Canadians do not have access to 19 of the 29 antibiotics that are called by the World Health Organization (WHO) as ‘antibiotics of a last resort’, a new federal audit report tabled in Parliament by Auditor General Karen Hogan found. It says Health Canada has not done enough to improve market access to new antimicrobial drugs available in …
Health Canada authorizes Pfizer-BioNTech Covid-19 vaccine targeting Omicron XBB.1.5
Ottawa – Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for individuals six months of age and older. Health Canada received Pfizer-BioNTech’s submission on June 29, 2023. After a thorough and independent review of the evidence, Health Canada has determined that the vaccine meets the Department’s stringent safety, efficacy and quality requirements. …
Highly mutated Coronavirus variant detected in Canada, what’s cure
Ottawa – Health officials in Canada has identified BA.2.86 variant of the Omicron coronavirus in the country – found in an individual in British Columbia who had not travelled outside the region. He has not currently in hospital, and the discovery does not alter the level of risk to the people in British Columbia. Canadian health authorities says overall virus …
MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE
Health Canada submission follows international recommendations to develop monovalent XBB.1.5 COVID-19 vaccines Moderna is prepared to deliver updated COVID-19 vaccines in time for the fall 2023 vaccination season TORONTO – Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has initiated the filing of a rolling New Drug Submission (NDS) to Health Canada …
Health Canada approved 1st vaccine for RSV
Ottawa – Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over. Manufacturer GSK says the federal agency has approved its new vaccine called Arexvy. Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and …